MicroRNA-150 is up-regulated in extranodal marginal zone lymphoma of MALT type

Cancer Genomics and Proteomics

Volumn 11, Issue 1, 2014, Pages 51-56

  Gebauer, Niklas ^a   Kuba, Johannes ^a   Senft, Andrea ^b   Schillert, Arne ^b   Bernard, Veronica ^a   Thorns, Christoph ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Gastritis; Lymphoma; Malignant transformation; MALT; MicroRNA

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; MICRORNA; MICRORNA 124A; MICRORNA 135A; MICRORNA 142 3P; MICRORNA 148A; MICRORNA 150; MICRORNA 153; MICRORNA 182; MICRORNA 198; MICRORNA 203; MICRORNA 335; MICRORNA 346; MICRORNA 375; MICRORNA 429; MICRORNA 494; MICRORNA 518B; MICRORNA 550; MICRORNA 572; MICRORNA 575; MICRORNA 7; MICRORNA LET 7F; MICRORNA RNU 6; UNCLASSIFIED DRUG; MIRN150 MICRORNA, HUMAN; PARAFFIN;

ARTICLE; FOLLOW UP; GASTRIC EXTRANODAL MARGINAL ZONE LYMPHOMA; GASTRITIS; GENE EXPRESSION PROFILING; GENETIC RECOMBINATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; MARGINAL ZONE LYMPHOMA; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CARCINOGENESIS; STOMACH LESION; STOMACH LYMPHOMA; UPREGULATION; CELL TRANSFORMATION; CHRONIC DISEASE; GENETICS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PATHOLOGY;

CELL TRANSFORMATION, NEOPLASTIC; CHRONIC DISEASE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL, MARGINAL ZONE; MICRORNAS; PARAFFIN EMBEDDING; UP-REGULATION;

EID: 84901466771     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ullrich A, Fischbach W and Blettner M: Incidence of gastric B-cell lymphomas: a population-based study in Germany. Ann Oncol 13: 1120-1127, 2002.
2. Swerdlow SH: WHO Classification of Tumors of Haematopoetic and Lymphoid Tissues: WHO, IARC 2008.
3. Thieblemont C, Bastion Y, Berger F, Rieux C, Salles G, Dumontet C, Felman P and Coiffier B: Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol 15: 1624-1630, 1997. (Pubitemid 27167402)
4. Hussell T, Isaacson PG, Crabtree JE and Spencer J: The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 342: 571-574, 1993. (Pubitemid 23259232)
5. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M and Isaacson PG: Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori . Lancet 342: 575-577, 1993. (Pubitemid 23259233)
6. Cerroni L, Zochling N, Putz B and Kerl H: Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol 24: 457-461, 1997. (Pubitemid 27432373)
7. Noack F, Lange K, Lehmann V, Caselitz J and Merz H: Primary extranodal marginal zone B-cell lymphoma of the fallopian tube. Gynecol Oncol 86: 384-386, 2002. (Pubitemid 35425541)
8. Hummel M, Oeschger S, Barth TF, Loddenkemper C, Cogliatti SB, Marx A, Wacker HH, Feller AC, Bernd HW, Hansmann ML, Stein H and Moller P: Wotherspoon criteria combined with B cell clonality analysis by advanced polymerase chain reaction technology discriminates covert gastric marginal zone lymphoma from chronic gastritis. Gut 55: 782-787, 2006. (Pubitemid 43764546)
9. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR and Isaacson PG: Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338: 1175-1176, 1991.
10. Fischbach W, Goebeler-Kolve ME, Dragosics B, Greiner A and Stolte M: Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut 53: 34-37, 2004. (Pubitemid 38083007)
11. Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, Ye H, Molina T, Bouhnik Y, Hamoudi RA, Diss TC, Dogan A, Megraud F, Rambaud JC, Du MQ and Isaacson PG: Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 357: 39-40, 2001. (Pubitemid 32056501)
12. Lee RC, Feinbaum RL and Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75 : 843-854, 1993. (Pubitemid 24014542)
13. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
14. Calin GA, Sevignani C, Dan Dumitru C, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M and Croce CM: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. P Natl Acad Sci USA 101 : 2999-3004, 2004. (Pubitemid 38327724)
15. Matsushima K, Isomoto H, Inoue N, Nakayama T, Hayashi T, Nakayama M, Nakao K, Hirayama T and Kohno S: MicroRNA signatures in Helicobacter pylori-infected gastric mucosa. Int J Cancer 128: 361-370, 2011.
16. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M and Croce CM: A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793-1801, 2005. (Pubitemid 41549891)
17. Thorns C, Kuba J, Bernard V, Senft A, Szymczak S, Feller AC and Bernd HW: Deregulation of a distinct set of microRNAs is associated with transformation of gastritis into MALT lymphoma. Virchows Arch 460: 371-377, 2012.
18. Saito Y, Suzuki H, Tsugawa H, Imaeda H, Matsuzaki J, Hirata K, Hosoe N, Nakamura M, Mukai M, Saito H and Hibi T: Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication. PLoS One 7 : e47396, 2012.
19. van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, Garcia-Sanz R, van Krieken JH, Droese J, Gonzalez D, Bastard C, White HE, Spaargaren M, Gonzalez M, Parreira A, Smith JL, Morgan GJ, Kneba M and Macintyre EA: Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17: 2257-2317, 2003. (Pubitemid 38072572)
20. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J, Rajewsky N, Bender TP and Rajewsky K: MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131 : 146-159, 2007. (Pubitemid 47498525)
21. Roehle A, Hoefig KP, Repsilber D, Thorns C, Ziepert M, Wesche KO, Thiere M, Loeffler M, Klapper W, Pfreundschuh M, Matolcsy A, Bernd HW, Reiniger L, Merz H and Feller AC: MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. Br J Haematol 142: 732-744, 2008.
22. Ghisi M, Corradin A, Basso K, Frasson C, Serafin V, Mukherjee S, Mussolin L, Ruggero K, Bonanno L, Guffanti A, De Bellis G, Gerosa G, Stellin G, D'Agostino DM, Basso G, Bronte V, Indraccolo S, Amadori A and Zanovello P: Modulation of microRNA expression in human T-cell development: targeting of Notch3 by miR-150. Blood 2011.
23. Gebauer N, Bernard V, Gebauer W, Feller AC and Merz H: MicroRNA Expression and JAK2 Allele Burden in Bone Marrow Trephine Biopsies of Polycythemia Vera, Essential Thrombocythemia and Early Primary Myelofibrosis. Acta Haematol 129 : 251-256, 2013.
24. Watanabe A, Tagawa H, Yamashita J, Teshima K, Nara M, Iwamoto K, Kume M, Kameoka Y, Takahashi N, Nakagawa T, Shimizu N, and Sawada K: The role of microRNA-150 as a tumor suppressor in malignant lymphoma. Leukemia 2011.
25. Wu Q, Jin H, Yang Z, Luo G, Lu Y, Li K, Ren G, Su T, Pan Y, Feng B, Xue Z, Wang X and Fan D: MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. Biochem Biophys Res Commun 392: 340-345, 2010.
26. Zhao JJ, Lin J, Lwin T, Yang H, Guo J, Kong W, Dessureault S, Moscinski LC, Rezania D, Dalton WS, Sotomayor E, Tao J and Cheng JQ: microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood 115: 2630-2639, 2010.
27. Monsalvez V, Montes-Moreno S, Artiga MJ, Rodriguez ME, Espiridion BS, Lozano M, Fernandez-de-Misa R, Rodriguez-Peralto JL, Piris MA and Ortiz-Romero PL: MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma. Mod Pathol 26: 617, 2013.
28. Cai J, Liu X, Cheng J, Li Y, Huang X, Ma X, Yu H, Liu H and Wei R: MicroRNA-200 is commonly repressed in conjunctival MALT lymphoma, and targets cyclin E2. Graefes Arch Clin Exp Ophthalmol 250: 523-531, 2012.